Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents. 2012

Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
School of Pharmaceutical Sciences, Shandong University, Jinan 250012, PR China.

Based on the core skeleton of the total synthesized bisbibenzyl marchantin C, riccardin D and plagiochin E, a series of brominated and aminomethylated derivatives of above three bisbibenzyls have been synthesized and their cytotoxic activity against KB, MCF-7 and PC3 cell lines has been preliminary evaluated. The bio-test results revealed that the brominated derivatives 21, 22, 24, 25 and 28 exhibited excellent antiproliferative activity, with IC(50) value lower than their parent compounds. As a most potent microtubule depolymerization agent, compound 28 was found to arrest cells at the G(2)/M phase of the cell cycle as determined by the flow cytometry assay in PC3 cell line. The remarkable biological profile and novel structure of these bisbibenzyl derivatives make them possible as promising candidates for clinical development as chemotherapeutic agents.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047028 Macrocyclic Compounds Cyclic compounds with a ring size of approximately 1-4 dozen atoms. Macrocycle Compounds,Spherands,Torands,Compounds, Macrocycle,Compounds, Macrocyclic
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050257 Tubulin Modulators Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. Microtubule Modulator,Tubulin Inhibitor,Tubulin Modulator,Tubulin Polymerization Inhibitor,Tubulin Polymerization Promoter,Tubulin Promoter,Microtubule Modulators,Tubulin Inhibitors,Tubulin Polymerization Inhibitors,Tubulin Polymerization Promoters,Tubulin Promoters,Inhibitor, Tubulin,Inhibitor, Tubulin Polymerization,Inhibitors, Tubulin,Inhibitors, Tubulin Polymerization,Modulator, Microtubule,Modulator, Tubulin,Modulators, Microtubule,Modulators, Tubulin,Polymerization Inhibitor, Tubulin,Polymerization Inhibitors, Tubulin,Polymerization Promoter, Tubulin,Polymerization Promoters, Tubulin,Promoter, Tubulin,Promoter, Tubulin Polymerization,Promoters, Tubulin,Promoters, Tubulin Polymerization

Related Publications

Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
August 2017, European journal of medicinal chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
October 2016, European journal of medicinal chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
September 2013, Cellular & molecular biology letters,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
November 2014, Chemical biology & drug design,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
January 2020, Bioorganic chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
April 2024, Anti-cancer agents in medicinal chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
March 2017, European journal of medicinal chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
October 2016, European journal of medicinal chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
August 1991, Journal of medicinal chemistry,
Juan Jiang, and Bin Sun, and Yan-yan Wang, and Min Cui, and Li Zhang, and Chang-zhi Cui, and Yan-feng Wang, and Xi-gong Liu, and Hong-xiang Lou
November 2020, Iranian journal of basic medical sciences,
Copied contents to your clipboard!